BPC-157 vs Thymosin Beta-4 — mechanism, half-life, dosing, and research status compared. Which is right for your protocol?
BPC-157 is a synthetic 15-amino acid peptide derived from gastric juice. It accelerates tissue repair, tendon healing, and gut protection via angiogenesis and growth hormone receptor upregulation. Orally bioavailable and stable in gastric acid. Extensive preclinical evidence acro...
Calculate BPC-157 dose →Thymosin Beta-4 (TB-4) is the full-length 43-amino acid actin-sequestering peptide from which the commonly used research fragment TB-500 (residues 17-23, LKKTETQ) is derived. TB-4 is the most abundant thymosin-family protein in virtually all mammalian cells, where it maintains th...
Calculate Thymosin Beta-4 dose →| Parameter | BPC-157 | Thymosin Beta-4 |
|---|---|---|
| Category | Healing & Recovery | Healing & Recovery |
| Research | Extensively Studied | Extensively Studied |
| Half-Life | 4–6 hours | ~30-60 min (plasma) |
| Typical Dose | 200–500 µg | 1.5-2.5 mg, 2-3x/week |
| Frequency | Once or twice daily | 2-3 times per week |
| Route | Subcutaneous / Oral | Subcutaneous, IV, Topical, Intranasal |
| FDA Status | Not Approved | Phase II |
Use ASCEND's free reconstitution calculator to get exact syringe draw amounts for your vial.
For research use only. Not medical advice. ASCEND does not conduct or endorse any specific research protocol. Always consult relevant scientific literature and regulatory guidelines.